Chapter Eight · The Unified Model of Tone

Input Meets Tone

Why the same cause yields different outcomes.

22 min read · By Dr. Jason Dulberg

In brief

The effect of any event on the body is never determined by the event alone. It is determined by how that event meets the organism's existing tone. An injury, a pathogen, a medication, a meal, an emotion, and a therapeutic input all arrive at a system with its own history, reserve, and range of responses. Tone is the hidden variable between cause and outcome.

Key points
  • There is no such thing as an input acting upon an empty body. Every input meets a state.
  • Diagnosis often marks the moment compensation became insufficient, not the moment disease began.
  • A restoring input carries each displaced measure in the same person toward its own midline, at the pace compensation allows. A masking input moves everyone the same direction.
  • Wilder fixed the dependence on starting level in 1958. The convergence, shared in direction across the displaced measures while compensation sets each one's pace, is the model's own signature.
  • Trials that deliver one predetermined input to everyone average a matched intervention and a mismatched one into a mean describing neither.
Definition

The input and tone principle

The rule that an outcome is produced by the interaction between an input and the organism's existing tone, rather than by the input alone. The same input passing through a different tone becomes a different biological event.

Two people undergo what looks like the same event. Internally it is never the same event, because it meets two different systems, and the outcome belongs to the meeting.

The law, stated plainly

Why does the same event yield different outcomes in different people? Chapter VII treated the therapeutic input as a special case of a far more general law, and that law is the clinical heart of the entire model. The effect of any event on the body is not determined by the event alone. It is determined by how the event interacts with the organism's existing tone. This is true of a therapeutic adjustment. It is equally true of an injury, an infection, a medication, a meal, an emotional shock, a night of lost sleep, or a word spoken by a person the patient loves.

There is no such thing as an input acting upon an empty body. Every input arrives at a system that already has a history, a structure, a reserve, an expectation, a receptor landscape, an autonomic state, a metabolic capacity, and a range of possible responses. The outcome is the product of that encounter. An input does not create an outcome. An input interacting with a tone creates an outcome.

The same input passing through a different tone becomes, in the most literal biological sense, a different event.

The outcome depends on the input and on the current tone. It depends on the accumulated history embodied in that tone, on the reserve available, and on the context in which the input arrives. It depends on the timing relative to the system's state, and on how strongly the input is coupled to the systems it can reach. Tone is the hidden variable standing between cause and outcome. Treated as one variable rather than a dozen, it turns a long list of clinical phenomena that have resisted the standard cause-and-effect model into expressions of a single principle.

Medicine already knows this, one field at a time

None of the individual observations behind this principle is new to medicine, and the model does not pretend otherwise. Pharmacogenomics knows that the same drug meets different metabolic machinery. Allostatic load knows that accumulated demand changes what the next demand costs. Pain science knows that identical tissue findings produce different experiences in different people.

Each field found the same fact inside its own boundary and gave it a local name. What the model contributes is the recognition that these are one fact, governed by one variable, statable as a single law rather than a dozen local exceptions. The unification of tone is the claim.

Health is a range of states, not a set of good numbers

Conventional assessment evaluates health through snapshots: a blood pressure, a glucose, a hormone level, an image, a range of motion, an inflammatory marker, the presence or absence of a symptom. A snapshot can miss the property that matters most, which is the range of organized states the system can enter and how effectively it moves between them.

A healthy system is not permanently relaxed, parasympathetic, pain-free, or free of inflammation. It can activate, defend, inflame, clot, tense, raise blood pressure, raise heart rate, mobilize glucose, suppress digestion, and prioritize survival, all appropriately. Its health lies in being able to leave those states when they are no longer required.

Health is therefore the breadth, flexibility, and coherence of the organism's available state-space, and disease is most often the narrowing of that space. A person may still function, but only by repeatedly using the same costly solutions: chronic sympathetic activation, muscular guarding, sensory suppression, inflammation, fatigue, dissociation, altered movement, hormonal compensation, or cognitive hypervigilance. The body is not necessarily failing. It may be succeeding through an increasingly expensive and limited strategy, and the cost of that strategy is what eventually surfaces as symptom.

Subclinical means compensated, not absent

Subclinical dysfunction is not the absence of dysfunction. It is compensated tonal distortion, a distortion the system is still hiding. Regulation moves through recognizable stages.

  1. Flexible adaptation. The system meets a demand, changes tone, resolves the demand, and returns with greater capacity than it began with.
  2. Compensated dysregulation. The original pattern is not fully resolved, but other systems take up the slack and function remains outwardly normal.
  3. Subthreshold symptoms. The person notices vague or intermittent changes: fatigue, tightness, reduced recovery, poor sleep, brain fog, irritability, altered digestion, headaches, exercise intolerance, or intermittent pain.
  4. Persistent symptomatic dysfunction. The compensatory system can no longer fully conceal the distortion.
  5. Diagnosable pathology. Measurable tissue, immune, endocrine, neurological, or organ-level changes become consistent enough to satisfy a diagnostic category.
  6. Structural or regulatory failure. The system loses enough adaptive capacity that it can no longer maintain essential function.

Diagnosis often marks the moment compensation became insufficient, not the moment disease began. This is why patients so often say their problem came out of nowhere. It did not come from nowhere. It crossed a threshold.

What appears above the surface is frequently the last stage of a long process below it. That process runs through altered autonomic regulation, reduced sensory fidelity, compensatory tension, and disrupted sleep. It runs on through metabolic strain, immune sensitization, reduced movement variability, predictive mismatch, psychological load, and declining recovery reserve. The symptom is the first thing the person notices and often the last thing to arrive.

The layer medicine has no category for

These stages describe a layer of illness the diagnostic system cannot name: people with real suffering, real functional loss, and no lesion. Medicine sorts them into residual bins and calls them functional, non-specific, medically unexplained, or subclinical. Every one of those names records the absence of a finding rather than the presence of a state.

The model holds that this layer is neither residual nor unexplained. It is regulatory, and it has its own organization. Counting it requires measures of regulation rather than measures of structure, which is why it has gone uncounted. The model expects that when it is counted properly it will prove to be the largest layer of illness there is.

Symptoms are outputs, not measurements of damage

Pain, fatigue, nausea, dizziness, anxiety, stiffness, and brain fog are real, and their intensity does not reliably correspond to the amount of identifiable tissue damage. A symptom is the organism's integrated interpretation of many things at once: tissue condition, threat, prior experience, expectation, immune signaling, sensory input, available energy, emotional meaning, context, and predicted consequences.

A symptom is the experiential projection of the system's current regulatory tone. Pain can arise when tissue damage is present and accurately represented. It also arises when a healed structure remains encoded as dangerous, when sensory gain has increased, or when inhibition has decreased. It arises when immune signaling has sensitized the system, or when movement predictions remain calibrated to an old injury. It arises when the body continues to protect against a threat that no longer exists, or when several weak signals converge into one significant protective output.

None of this makes pain imaginary. It means pain is real as an experience even when its generating cause is distributed, historical, predictive, or regulatory rather than visible as a single lesion. The stored neural patterns and the persistence of dysfunction after the original trigger has resolved, described in Chapter VI, are exactly the machinery the model requires.

Idiopathic disease is maintained by an organization, not caused by a hidden object

Idiopathic means the cause has not been established. It does not mean the condition has no cause. The standard diagnostic model works beautifully where a single dominant cause exists: one pathogen, one infection; one mutation, one protein disorder; one occluded vessel, one infarction.

Many chronic conditions are not built that way. They arise from a network in which no single factor is sufficient. The network holds genetic susceptibility, epigenetic history, prior immune activation, environmental exposure, nutrition, and sleep loss. It also holds chronic psychological demand, mechanical injury, altered movement, autonomic dysregulation, endocrine state, microbiome changes, medication history, social conditions, and ordinary biological variation. Together these reshape the system's tonal landscape until a new pathological state becomes stable.

That last word is the key one. A disease can become an attractor, a state toward which the system repeatedly returns and which, once established, maintains itself. Pain drives guarding, which reduces movement, which weakens tissue capacity, which makes movement more threatening, which produces more pain. Stress activation degrades sleep, which drives inflammation, which worsens regulation, which increases stress sensitivity. Immune activation produces neural sensitization, which alters autonomic output, which alters immune regulation, which sustains the activation. In each loop the original trigger may vanish while the pattern persists.

Nonlinear physics supplies the reason a pattern can hold itself up with nothing holding it. A solitary wave persists because two opposing tendencies cancel exactly: the spreading that would disperse it and the steepening that would collapse it. Nothing external maintains the form. The balance is the form. A pathological tonal state is stable on the same terms, and the loops above are the opposing tendencies that hold it in place.

Some idiopathic diseases are therefore not caused by a hidden object waiting to be found. They are maintained by a hidden organization, a self-reinforcing relationship among systems. That is a different kind of thing to look for and a different kind of thing to treat.

What an attractor predicts

This is stated as a claim with consequences that can be checked. A condition held in place by a self-reinforcing organization should behave the way stable states behave. It should show hysteresis, meaning the perturbation required to leave the state exceeds the one that produced it, and the path out does not retrace the path in. That follows directly from a self-maintaining balance, because dismantling one takes more than entering one did. It should resist correction of any single variable while responding to several changed together. And it should improve in steps rather than in proportion to the input.

A chronic condition that shows hysteresis, resists single-variable correction, and improves in steps rather than in proportion counts as evidence for the attractor account.

The site of a disease is not the source of it

The same systemic disturbance can express as migraine in one person and gut symptoms in another. It becomes muscle guarding in a third, panic in a fourth, hormonal disruption in a fifth, inflammatory skin disease in a sixth, and fatigue in a seventh. Each organism has a different constraint landscape, and the disturbance surfaces wherever that particular body is least able to absorb it.

Disease tends to localize where there is inherited vulnerability, prior injury, reduced vascular supply, altered receptor density, previous infection, scar tissue, mechanical stress, weak metabolic reserve, immune memory, developmental difference, or heavily used circuitry. The place where a system expresses disease is not necessarily where the disease process began. The symptomatic organ may simply be the one with the least remaining capacity to compensate. This is a major clinical principle, and it is one more reason the symptomatic site and the critical leverage point are so often different.

The same logic governs treatment. The most symptomatic site is frequently a compensation splinting a primary distortion elsewhere, so the loudest tissue is the weakest link rather than the origin. Input delivered to the compensation reinforces the brace. Input delivered to the primary driver releases it. Much of the clinical art lies in telling the two apart and declining to chase the symptom in pursuit of the higher-leverage node.

Why two clinicians disagree about the same case

Clinicians who disagree are usually not disagreeing about the findings. They are locating the origin at different levels, and the level a clinician stops at is the level their training taught them to stop at. One locates it at the site of symptoms. A second locates it at the segment or circuit whose regulation of that site has degraded. A third locates it one step further back, at whatever produced the compensation in the first place.

All three levels are real, all three are treatable, and a case can genuinely live at any of them. Recurrence is the useful signal. When a well-executed input resolves a problem that then returns unchanged, the information is not that the input failed but that the origin sits one level further back.

This is a reasoning framework rather than a mechanism, and it carries its own warning. A clinician who insists that every symptom is secretly a neck, or secretly a mind, or secretly a gut, has not found the deepest level. They have merely relocated the first one and stopped. Accuracy here is not altitude. Accuracy is correspondence between the level of the intervention and the level at which this particular body's problem actually lives.

Why the same experience marks one person and not another

Two people may undergo what looks externally like the same event. Internally it is never the same event, because it meets different developmental histories, prior traumas, degrees of social support, beliefs, expectations, body states, sleep reserves, hormonal conditions, meanings, and coping repertoires.

One person integrates the event and gains capacity. Another protects briefly and then resolves. Another forms a persistent defensive state. Another collapses. Another shows no obvious effect until a later event pushes the system across a threshold.

Trauma, in the model, is defined not solely by what happened but by the relationship between the demand and the system's capacity to integrate it. The impact of an event scales with its demand, its meaning, and its novelty, and inversely with the integrative capacity available at the moment it arrives. An experience is not stored according to its objective size but according to the system's capacity to integrate it at that moment. That is why something apparently minor can profoundly mark one person while another metabolizes a severe event without lasting dysfunction.

Sensitivity is a property of coupling

People are not equally connected to every kind of input. One person is highly responsive to mechanical input, another to sound, another to medication. Another responds to interpersonal conflict, an inflammatory food, sleep disruption, hormonal fluctuation, an environmental chemical, or a change in routine. The same input scarcely registers in someone else.

Sensitivity depends on receptor availability, coupling strength, threshold, amplification, inhibition, prior sensitization, current state, and the number of systems connected to that input. A small input produces a large response when it enters a highly coupled node. A large input produces little response when the system is insensitive to it, when the input misses the relevant pathway, or when the system buffers it. It produces little response when the receptors and transition pathways it would need are unavailable. This is the familiar nonlinear pattern seen throughout healthcare. The size of the response does not reveal the size of the input. It reveals the input's relationship to the receiving system.

The principle holds all the way down to the single cell. A neuron's response to an identical input is set by its own genetic disposition and by its present condition, whether the organism that houses it is fed, rested, and resourced or depleted, sleepless, and inflamed. The same signal arriving at the same synapse can be integrated calmly or read as a threat and amplified down the line. What is true of the neuron is true of the organ and true of the whole person.

The input does not carry the outcome. The system that meets it does.

A medication is an input meeting a system

A medication has real pharmacological properties, and its effect is never produced by the molecule by itself. The molecule enters a particular organism with its own receptor distribution, gene expression pattern, hepatic metabolism, and renal clearance. It also meets a gut microbiome, an immune and autonomic state, an endocrine environment, a nutritional status, a concurrent medication load, an expectation, a disease stage, and a prior exposure history.

The same molecule at the same dose can therefore produce benefit, no meaningful effect, a paradoxical effect, an excessive effect, side effects, tolerance, withdrawal, or changes that appear only over time. A medication is a structured chemical input that alters coupling, signaling, and transition probabilities within an existing tonal system. It does not simply do one thing. It changes the constraint landscape.

Blocking a receptor may reduce one pathway while prompting the system to increase receptor expression, reroute signaling, alter transmitter production, change metabolism, or shift another regulatory axis. This is why the immediate effect and the long-term adaptation so often differ. Two patients with the same diagnosis may require different drugs, because the diagnosis names the visible endpoint rather than the pathway that produced it. Hypertension, depression, inflammation, and pain can each arise from several different underlying organizations, so the same diagnosis can contain several distinct tonal pathologies, and the same medication interacts differently with each. This is why treatment based on diagnostic category alone produces averages rather than certainties.

The sharpest prediction the model makes

This exposes a distinction the input and tone principle makes unavoidable. Chapter VII drew the difference between masking a value and restoring the regulator that governs it. A medication that lowers blood pressure lowers it regardless of where the patient began, because it acts on a single mechanism in a single direction. An input that restores the tone of the regulatory loop should instead move the value toward the body's own homeostatic midpoint from whichever side it was displaced. The same intervention brings a high value down and a low value up.

Bidirectional return, lowering what is high and raising what is low rather than pushing in one direction regardless of starting point, is the signature the model predicts will distinguish tonal restoration from pharmacological masking.

Stating the test makes the stake concrete. Assemble two groups on the same variable, one whose measure sits above its healthy window and one whose measure sits below it. The variable can be blood pressure, heart rate variability, resting muscle tone, or any quantity with a defined healthy range. Specify the input and the site in advance, by a tone measure taken before the outcome is known, so that matching cannot be judged after the fact.

Deliver it to half of each group and give the other half a sham matched for force, contact time, and attention. The sham arm is not optional, because stratifying by starting side produces some convergence from regression to the mean alone.

The model predicts convergence in the treated arms that exceeds the sham arms. The two groups move toward each other and toward the middle of the range, and the variance of the treated cohort narrows around the midpoint. It predicts further that a single well placed input can do this for every displaced measure in that person, however many of them there are, which no account assembled from independent set points expects. The body is a nonlinear system, and its changes are nonlinear too: compensation decides how far each displaced measure moves on any one response, so some travel at once while others are held until the reserve carrying them is released. What the model stakes itself on is the shared direction, not a uniform distance. The measures that were already sitting inside their range should stay there, since there is nothing for a restored regulator to correct.

Convergence from both directions, each group moving toward the middle from the side it began on, confirms the prediction. So does convergence in the treated arms that exceeds what the sham produces. The direction of the expected result is fixed before the data arrive, which is what makes this a prediction rather than an interpretation.

Wilder's law, and what the model adds to it

The lineage of this prediction is older than the model. Wilder documented in 1958 that the response to a stimulus depends on the level from which the stimulus starts, and called it the law of initial value. What the model adds is not the dependence but the convergence, and not in one variable but across all of them. A restored regulator can carry every displaced measure in the same person toward its own midline, however many measures are displaced and whichever side each one left from. It does not carry them in step. A nonlinear system answers nonlinearly, so compensation decides which measures move on a given response and which are held, and over a course of care the model expects the majority to return to their healthy ranges. No assembly of independent set points predicts even the shared direction, and Wilder's law alone does not predict it either.

The multi-measure convergence, read across a course of care and exceeding sham, is the signature that belongs to this model.

Why intervention research underestimates what it studies

The outcome depends on the correspondence between an input and each individual's constraint structure. A trial that delivers the same predetermined input to everyone averages a well-matched intervention and a mismatched one across a sample that was never stratified by tone. A standardized manipulation of a fixed segment is such a trial, and so is a single drug at a single dose. The responders for whom the input fit and the non-responders for whom it did not are collapsed into a modest mean that describes neither, and a genuinely large effect reads as weak.

The model states this as a prediction rather than a complaint. Stratify a sample by a tone measure recorded before any input is given, and specify each person's leverage point from that measure. Then randomize between an input delivered there and the identical input delivered to a site the measure did not select.

The model predicts a substantially larger effect in the matched arm and a modest one in the mismatched arm, and it predicts that pooling the two reproduces the small average the literature keeps reporting. A larger effect in the matched arm confirms it, and confirms with it the claim that correspondence rather than force is the active ingredient. Fixing the site in advance is what keeps this a prediction. A leverage point identified after the result is known explains everything and forecasts nothing, and the model does not claim that privilege. The field does not lack evidence so much as it lacks evidence organized around the correct variable.

Placebo and nocebo have a causal home

Expectation, trust, ritual, meaning, the practitioner relationship, the environmental context, and the perceived safety of a situation all change the organism's tone. Through it they change attention, threat interpretation, autonomic state, muscular guarding, pain modulation, motivation, behavior, sleep, adherence, and physiological regulation.

The total effect of any intervention is the sum of three things: its specific physical or chemical effect, the contextual regulatory effect of the meaning around it, and the system's own response. Inside a living person these cannot always be cleanly separated. Nocebo is the same mechanism inverted, where expectation and context move the system toward threat, sensitization, guarding, and adverse interpretation.

Meaning is not outside biology. Meaning is a high-order tonal input that changes lower-order regulation through the body's recursive architecture. This does not mean expectation cures every disease. It means expectation participates in the final state that treatment produces.

Sudden change is what nonlinear systems do

Spontaneous remission and sudden deterioration appear inexplicable under a linear model and are natural under a tonal one. A system can cross back out of a pathological state when enough of its constraints change at once. Sleep improves, threat decreases, a relationship changes, inflammation resolves, movement returns, a hormonal cycle shifts, an infection clears, nutrition improves, a high-leverage intervention lands, or several small changes accumulate.

The remission may look sudden while the system has been approaching a transition threshold for some time. Water stays liquid as it cools, then freezes abruptly once it crosses a critical boundary. Nonlinear systems can change gradually beneath the surface and reorganize sharply at the point of transition. The same principle explains why a person who has compensated for years can appear to fall apart after one small stressor. The final stressor is the last input needed to cross the boundary rather than the primary cause.

Many chronic illnesses do not sit in a binary of healthy or diseased. They move among relatively stable configurations: low symptom and high capacity, moderate compensation, inflammatory flare, exhaustion, partial recovery, renewed flare. Each state changes the likelihood of entering the next, which is why a patient may tolerate a food, a workout, a medication, or a stressful event on one day and not on another. The input is similar and the baseline tone is different. Tolerance is a relationship between the input and the system's current reserve.

Comorbidity is one dysregulation with several addresses

Pain, sleep disruption, anxiety, digestive symptoms, fatigue, headaches, and inflammatory complaints travel together so reliably because one loss of adaptive regulation reaches all of them. An autonomic rigidity can alter digestion, degrade sleep, and drive muscle guarding. The same rigidity amplifies sensory processing, changes vascular tone, dysregulates immune activity, and reduces emotional flexibility.

This does not mean every comorbidity shares one cause, and it does not mean a shared loss of regulation must surface in every system it reaches. It means interconnected systems can express a shared loss of regulation through several diagnostic categories at once, and that they do so when compensation can no longer keep those categories quiet. Chapter VI named four such conditions and the shared state beneath them. Comorbidity, seen this way, is the convergence this paper set out to describe.

Why several different treatments help the same condition

A chronic condition maintained by a loop with multiple access points can be interrupted at any of them. An adjustment changes sensory and mechanical input. A medication reduces inflammatory or neural amplification. Psychotherapy changes threat interpretation. Exercise changes capacity and prediction. Nutrition changes metabolic and inflammatory conditions. Sleep restoration rebuilds regulatory reserve. Surgery changes a structural constraint. Social support changes the perception of safety and available resources.

The treatments are not identical and they are not interchangeable. Each can work because each perturbs a different component of the same self-reinforcing organization.

And why treatment sometimes worsens things first

A system organized around compensation can experience change as destabilization. A protective pattern that is costly but still serving a purpose can, when removed before another strategy is in place, temporarily increase pain, fatigue, emotional intensity, instability, or sensory awareness.

This does not automatically prove that worsening is healing. Worsening can equally mean the intervention was inappropriate, excessive, mistimed, or harmful. The disciplined interpretation is that a good intervention expands adaptive possibilities while a poor one either fails to change the relevant constraints or narrows the system further. Response is judged through function, durability, physiological stability, adverse effects, and expanding or narrowing capacity, not through the drama of an immediate reaction.

Dose is nonlinear, because the system has to be able to use it

In a simple system, twice the dose produces roughly twice the effect. Living systems rarely oblige. A dose may fall below the threshold of registration and do nothing. It may land within an effective integration window and produce useful reorganization. It may exceed a tolerance threshold and provoke defense, or rise high enough to trigger destabilization and injury.

Too little input is not registered. Matched input is integrated. Excessive input becomes defense, noise, or damage. This holds, in its own units, for medications, exercise, manual force, sensory exposure, psychotherapy, fasting, temperature, and training alike. More is not inherently better. The correct dose is the amount the system can actually use to enter a more adaptive state.

A normal laboratory value can hide an abnormal system

Reference ranges describe populations, and a person can sit comfortably inside a population range while having drifted far from their own functional baseline. Most standard tests also measure quantity rather than organization. They record an average level rather than its variability, and a resting value rather than a response capacity. They record an isolated molecule rather than a network relationship, a structure rather than its regulation, and a single moment rather than a temporal pattern.

The model predicts that early disease announces itself in the dynamics before it appears in the values. It shows in variability, coupling, recovery time, responsiveness, temporal coordination, threshold, and transition capacity, while every static number still sits inside its reference range.

The test is a longitudinal cohort measured on both panels at once, a standard laboratory panel and a battery of dynamic measures, followed until a fraction of it becomes ill. The model predicts that the dynamic measures move first and predict who converts. If the dynamic measures move first and carry predictive information the static ones lack, the prediction is confirmed.

The future of tonal assessment therefore lies less in static measurement and more in dynamic challenge-and-response testing. How heart rate responds and recovers. How glucose moves after a demand and returns. How the nervous system adapts during learning. How movement variability changes under load. How inflammation resolves. How sleep restores capacity. How a person responds to and recovers from an intervention. The most informative variable is frequently not the starting number but the system's ability to change appropriately and return. Endpoints that read tone directly would measure heart rate variability and baroreflex sensitivity, resting-state EEG coherence, default-mode and salience-network connectivity, interoceptive accuracy, and autonomic phenotype.

How dysfunction develops, in seven stages

These threads gather into a single account. Demand arrives, when the person meets a mechanical, chemical, infectious, metabolic, emotional, cognitive, or social challenge. Registration follows, as the organism detects and interprets that challenge through its existing tone. Then response, as neural, immune, endocrine, metabolic, mechanical, and behavioral systems reorganize to meet it.

Then either integration or incomplete resolution, in which the system either incorporates the event and returns with expanded capacity or retains a protective pattern. Then compensation, as other systems reorganize to preserve immediate function around the unresolved pattern. Then stabilization, as the compensatory pattern becomes an attractor and begins reproducing itself through feedback. And finally expression, as the pattern surfaces as symptoms, functional loss, measurable pathology, or a named disease.

Seen through these stages, disease is not merely damaged structure. Disease is the persistence of an organization that no longer serves the present needs of the whole.

The answer to the oldest question in medicine

Two people with the same diagnosis, the same exposure, the same injury, the same treatment, and apparently the same anatomy can have radically different outcomes. The model answers that they do not have the same system. They have different accumulated histories, different present organizations, different compensations, different vulnerabilities, different meanings, different coupling relationships, different reserves, different transition thresholds, and different possible futures.

Disease does not emerge from cause alone. It emerges from the interaction between cause and organization. Healing does not emerge from treatment alone. It emerges from the interaction between treatment and organization. Tone is the hidden variable between input and outcome.

The body is not a passive object upon which causes act. It is an active, historical, self-organizing system that transforms every cause according to its existing tone. A symptom is not simply what has happened to the body. It is what the whole organism is currently doing with what has happened to it.

Built on the work of
Wilder · the law of initial valueMcEwen and Stellar · allostatic loadRelling and Evans · pharmacogenomicsKent and Hayward · heterogeneity of treatment effectScheffer · critical transitionsColloca and Barsky · placebo and noceboWoolf · central sensitizationLipsitz and Goldberger · loss of complexityMarder · neuromodulation of circuits
References for this chapter
  1. Thayer JF, Lane RD. A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord. 2000;61(3):201-216.
  2. Wilder J. Modern psychophysiology and the law of initial value. Am J Psychother. 1958;12(2):199-221.
  3. Brinjikji W, Luetmer PH, Comstock B, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 2015;36(4):811-816.
  4. Lipsitz LA, Goldberger AL. Loss of 'complexity' and aging. Potential applications of fractals and chaos theory to senescence. JAMA. 1992;267(13):1806-1809.
  5. Scheffer M, Bascompte J, Brock WA, et al. Early-warning signals for critical transitions. Nature. 2009;461(7260):53-59.
  6. van de Leemput IA, Wichers M, Cramer AOJ, et al. Critical slowing down as early warning for the onset and termination of depression. Proc Natl Acad Sci U S A. 2014;111(1):87-92.
  7. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2-S15.
  8. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351(9101):478-484.
  9. Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343-350.
  10. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153(18):2093-2101.
  11. Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics. 2011;52(3):263-271.
  12. Scheffer M, Carpenter S, Foley JA, Folke C, Walker B. Catastrophic shifts in ecosystems. Nature. 2001;413(6856):591-596.
  13. Marder E. Neuromodulation of neuronal circuits: back to the future. Neuron. 2012;76(1):1-11.
  14. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462-467.
  15. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 2004;3(11):679-684.
  16. Aarons RD, Nies AS, Gal J, Hegstrand LR, Molinoff PB. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980;65(5):949-957.
  17. Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298(10):1209-1212.
  18. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005;34(1):215-220.
  19. Kent DM, Steyerberg E, van Klaveren D. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ. 2018;363:k4245.
  20. Colloca L, Barsky AJ. Placebo and nocebo effects. N Engl J Med. 2020;382(6):554-561.
  21. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet. 2001;357(9258):757-762.
  22. Challis GB, Stam HJ. The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol. 1990;29(5):545-550.
  23. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354(9182):936-939.
  24. Calabrese EJ, Baldwin LA. Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol. 2003;43:175-197.
  25. Harris EK. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem. 1974;20(12):1535-1542.
  26. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A. 2001;98(2):676-682.
  27. Seeley WW, Menon V, Schatzberg AF, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007;27(9):2349-2356.
  28. Garfinkel SN, Seth AK, Barrett AB, Suzuki K, Critchley HD. Knowing your own heart: distinguishing interoceptive accuracy from interoceptive awareness. Biol Psychol. 2015;104:65-74.

Every source in the paper is listed on the references page.

Common questions

How can a condition be real if nothing shows up on tests?

Because most standard tests measure quantity rather than organization: an average rather than its variability, a resting value rather than a response capacity, a single moment rather than a temporal pattern. The model predicts early disease announces itself in the dynamics while every static number still sits inside its reference range. A longitudinal cohort measured on both panels should show the dynamic measures moving first and predicting who converts.

What distinguishes an intervention that restores from one that masks?

The direction of movement from different starting points. A drug that lowers blood pressure lowers it regardless of where the patient began. An input that restores the regulator should move the value toward the body's own midpoint from either side, carrying a high measure down and a low one up. It can do so for every displaced measure in that person, with compensation deciding which ones move first, while the measures already inside their range stay where they are.

Hasn't medicine always known that the starting point matters?

Wilder documented it in 1958 and called it the law of initial value: the response to a stimulus depends on the level the stimulus starts from. The model adds something Wilder's law does not contain. It predicts convergence rather than dependence, and it predicts that convergence across the displaced measures in the same person, from whichever side each one was displaced, at the pace compensation allows. Multi-measure convergence that exceeds sham, read across a course of care, is the signature belonging to this model.

Why do trials of manual therapy report such small effects?

Because delivering one predetermined input to everyone averages a matched intervention and a mismatched one across a sample never stratified by tone. Responders and non-responders collapse into a mean that describes neither. The model predicts that stratifying by a tone measure recorded in advance, and specifying each person's leverage point from it, produces a substantially larger effect in the matched arm. Pooling the two arms reproduces the familiar small average.

Where chiropractic craftsmanship meets nervous system regulation.

Reserve a consultation